Lowenstein Sandler represented Celldex Therapeutics in the offering. Celldex Therapeutics, Inc. (Celldex) (Nasdaq: CLDX) executed its $287.5 million public offering of common stock. Jefferies, SVB Leerink,...
Celldex Therapeutics’ $287.5 Million Common Stock Offering
Partners Group’s Acquisition of Dimension Renewable Energy
Lowenstein advised Dimension Renewable Energy on the deal. Dimension Renewable Energy (Dimension), a distributed energy platform focusing on community solar and battery storage across the United...
Indorama Ventures’ Acquisition of CarbonLite’s Texas PET Recycling
Lowenstein represented Indorama Ventures in the transaction. Indorama Ventures (BKK: IVL), a global chemicals producer, completed its acquisition of CarbonLite Holdings’ facility in Texas as part of...
Avadim Health’s Chapter 11 Bankruptcy
Lowenstein Sandler has been selected as counsel to the Official Committee of Unsecured Creditors in the Chapter 11 bankruptcy case of Avadim Health, Inc. Avadim Health,...
Halma’s Acquisition of PeriGen
Lowenstein Sandler represents PeriGen Inc. in the transaction. Halma plc executed the acquisition of PeriGen Inc. (PeriGen), a leading provider of perinatal health care software solutions. PeriGen’s...
Century 21 Department Stores’ Plan of Liquidation
Lowenstein represented the official committee of unsecured creditors. Century 21 Department Stores’ Plan of Liquidation was approved by the United States Bankruptcy Court for the Southern...
Knotel’s Chapter 11 Bankruptcy
Lowenstein Sandler acted as counsel to the Official Committee of Unsecured Creditors in the Chapter 11 bankruptcy cases of Knotel, Inc., and over 200 of its...